Vault-13

BIOPHARMA CREDIT PLC BOPCF

COM · Closed-End Fund · CUSIP G12808104

1 institutional holders +0 vs Q4 2022
1,910,4031.9m shares reported held*
$1.8mreported value*
0 new 1 added 0 reduced 0 sold out net bought ≈ $75.2k (+78.2k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.96.

Trends to Q1 2023

Institutional holders

Managers reporting a position, each quarter

001Q3 22: 1Q4 22: 1Q1 23: 11Q3 22Q4 22Q1 23
Numbers
QuarterHolders
Q3 20221
Q4 20221
Q1 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q4 22: 1 bought or addedQ4 22: 0 cut or sold outQ4 22Q1 23: 1 bought or addedQ1 23: 0 cut or sold outQ1 23
Numbers
QuarterBought or addedCut or sold out
Q4 202210
Q1 202310

Biggest buyers

Aubrey Capital Management Ltd Added +78,212+78.2k

Biggest sellers

None

Holders, Q1 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Aubrey Capital Management Ltd 1.07% of their portfolio EDINBURGH, X0 1,910,4031.9m $1.8m $1.8m 1.07% Added +78.2k +78,212